Choksi Laboratories Ltd

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook, even as its fundamental and financial metrics remain under pressure. The revised rating highlights a mild improvement in technical indicators, balanced against persistent challenges in valuation and financial trends.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has been downgraded from a Sell to a Strong Sell rating as of 7 April 2026. The downgrade reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, signalling caution for investors amid challenging market conditions.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing fundamental challenges, signalling a cautious but slightly more optimistic stance from analysts.

Choksi Laboratories Ltd, a micro-cap player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 27 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and ongoing valuation concerns, signalling heightened risks for investors amid a challenging market environment.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 March 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental challenges, prompting a reassessment of its valuation and market positioning.

Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Choksi Laboratories Ltd, a player in the Healthcare Services sector, has touched a new 52-week low of Rs.81.85 today, marking a significant decline amid ongoing market pressures and sector underperformance. The stock’s recent performance highlights persistent challenges reflected in its valuation and financial metrics.

Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Choksi Laboratories Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 17 Feb 2026. This shift reflects deteriorating technical indicators, stagnant financial performance, and a challenging valuation backdrop, signalling caution for investors amid underwhelming market returns and weak fundamental metrics.

Choksi Laboratories Ltd, a healthcare services company, has seen its investment rating downgraded from Strong Sell to Sell following a reassessment of its financial performance, valuation, technical indicators, and overall quality metrics. The downgrade reflects a cautious stance amid flat quarterly results, subdued financial trends, and mixed technical signals, despite some attractive valuation parameters.

Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 07 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Choksi Laboratories Ltd., a micro-cap contract testing and analytical services provider with a market capitalisation of ₹85.00 crores, reported a net profit of ₹0.31 crores for Q3 FY26 (October-December 2025), representing a sequential increase of 29.17% quarter-on-quarter but a substantial 181.82% surge year-on-year from ₹0.11 crores in Q3 FY25. However, the headline profit growth conceals troubling underlying trends, including persistent margin compression, an extraordinarily high tax rate of 65.56%, and declining operating efficiency that raise serious questions about the sustainability of this performance.

Choksi Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.